deCODE genetics/Amgen Inc., Reykjavik, Iceland.
Wellcome Sanger Institute, Cambridge, UK.
Nat Commun. 2020 Nov 25;11(1):5976. doi: 10.1038/s41467-020-19733-6.
Preeclampsia is a serious complication of pregnancy, affecting both maternal and fetal health. In genome-wide association meta-analysis of European and Central Asian mothers, we identify sequence variants that associate with preeclampsia in the maternal genome at ZNF831/20q13 and FTO/16q12. These are previously established variants for blood pressure (BP) and the FTO variant has also been associated with body mass index (BMI). Further analysis of BP variants establishes that variants at MECOM/3q26, FGF5/4q21 and SH2B3/12q24 also associate with preeclampsia through the maternal genome. We further show that a polygenic risk score for hypertension associates with preeclampsia. However, comparison with gestational hypertension indicates that additional factors modify the risk of preeclampsia.
子痫前期是一种严重的妊娠并发症,影响母婴健康。在对欧洲和中亚母亲的全基因组关联荟萃分析中,我们在 ZNF831/20q13 和 FTO/16q12 区域的母系基因组中鉴定出与子痫前期相关的序列变异。这些变异先前与血压(BP)相关,FTO 变异也与体重指数(BMI)相关。对 BP 变异的进一步分析表明,MECOM/3q26、FGF5/4q21 和 SH2B3/12q24 上的变异也通过母系基因组与子痫前期相关。我们进一步表明,高血压的多基因风险评分与子痫前期相关。然而,与妊娠期高血压的比较表明,其他因素会改变子痫前期的风险。